Potential for repurposing oral hypertension/diabetes drugs to decrease asthma risk in obesity.
Akshay SoodClifford QuallsAllison MurataPhillip J KrothJenny MaoDavid S SchadeGlen MurataPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Use of ACE-I and/or TZD was associated with a lower risk for incident asthma in overweight/obese patients with diabetes mellitus and/or hypertension.
Keyphrases
- weight loss
- type diabetes
- blood pressure
- metabolic syndrome
- chronic obstructive pulmonary disease
- cardiovascular disease
- lung function
- glycemic control
- insulin resistance
- weight gain
- adipose tissue
- physical activity
- allergic rhinitis
- angiotensin ii
- cystic fibrosis
- angiotensin converting enzyme
- obese patients
- breast cancer risk